Titan Biotech Limited (BOM:524717)

Titan Biotech Statistics

Total Valuation

Titan Biotech has a market cap or net worth of INR 12.30 billion. The enterprise value is 12.36 billion.

Market Cap	12.30B
Enterprise Value	12.36B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

Titan Biotech has 41.32 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	41.32M
Shares Outstanding	41.32M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	n/a
Float	12.66M

Valuation Ratios

The trailing PE ratio is 45.24.

PE Ratio	45.24
Forward PE	n/a
PS Ratio	6.39
PB Ratio	7.39
P/TBV Ratio	7.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	45.43
EV / Sales	6.42
EV / EBITDA	34.16
EV / EBIT	39.37
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	0.26
Debt / FCF	n/a
Interest Coverage	73.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	12.89%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.25%
Revenue Per Employee	4.12M
Profits Per Employee	582,503
Employee Count	467
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Titan Biotech has paid 82.64 million in taxes.

Income Tax	82.64M
Effective Tax Rate	23.30%

Stock Price Statistics

The stock price has increased by +216.34% in the last 52 weeks. The beta is 0.37, so Titan Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+216.34%
50-Day Moving Average	223.77
200-Day Moving Average	167.02
Relative Strength Index (RSI)	65.05
Average Volume (20 Days)	139,731

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Titan Biotech had revenue of INR 1.93 billion and earned 272.03 million in profits. Earnings per share was 6.58.

Revenue	1.93B
Gross Profit	985.82M
Operating Income	288.46M
Pretax Income	354.67M
Net Income	272.03M
EBITDA	331.70M
EBIT	288.46M
Earnings Per Share (EPS)	6.58

Balance Sheet

The company has 35.99 million in cash and 88.50 million in debt, with a net cash position of -52.51 million or -1.27 per share.

Cash & Cash Equivalents	35.99M
Total Debt	88.50M
Net Cash	-52.51M
Net Cash Per Share	-1.27
Equity (Book Value)	1.66B
Book Value Per Share	40.29
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 51.20%, with operating and profit margins of 14.98% and 14.13%.

Gross Margin	51.20%
Operating Margin	14.98%
Pretax Margin	18.42%
Profit Margin	14.13%
EBITDA Margin	17.23%
EBIT Margin	14.98%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.14%.

Dividend Per Share	0.40
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	0.13%
Earnings Yield	2.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on February 20, 2026. It was a forward split with a ratio of 5.

Last Split Date	Feb 20, 2026
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1